New Chagas research unravels decades-long mystery of how the tropical disease progresses
New research from Tulane University may shed light on how parasite strain diversity can impact Chagas disease progression and severity.
Sep 5, 2023
0
1
New research from Tulane University may shed light on how parasite strain diversity can impact Chagas disease progression and severity.
Sep 5, 2023
0
1
A team of researchers at the University of Kentucky has found that a drug used to treat multiple sclerosis (MS) is potentially effective as a therapy for Alzheimer's disease.
Sep 1, 2023
1
37
A team of researchers from Yale University and other institutions globally has developed an innovative patient triage platform powered by artificial intelligence (AI) that the researchers say is capable of predicting patient ...
Aug 29, 2023
0
6
Our movements are controlled by multiple neural pathways that connect the brain and spinal cord. In particular, neurons in the cerebral cortex send commands to the motor neurons in the spinal cord and then to the muscles, ...
Aug 18, 2023
1
67
Trust your gut? Your doctor likely will, too. Probiotics engineered to sense and report signs of bowel inflammation could deliver firsthand knowledge of your system's inner workings—provided they are not killed or dispersed ...
Aug 16, 2023
0
66
Alzheimer's disease is a progressive neurodegenerative disease estimated to affect 6 million Americans and 33 million people worldwide. Large numbers of those affected have not yet been diagnosed.
Aug 14, 2023
0
647
The U.S. Food and Drug Administration has approved Izervay (avacincaptad pegol intravitreal solution) for the treatment of geographic atrophy secondary to age-related macular degeneration.
Aug 10, 2023
0
2
New research from The Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has successfully reversed hearing loss in mice.
Aug 9, 2023
0
68
In their continuing work to limit the impact of COVID-19, Emory University researchers have, for the first time in nonhuman primates, studied how modulating the signaling of type 1 Interferon (IFN-I), one of the body's initial ...
Aug 8, 2023
0
28
By the time multiple sclerosis is normally diagnosed—when brain lesions appear on magnetic resonance imaging scans—the patient can have irreversible damage and treatment options can be limited. But in a Stanford Medicine-led ...
Aug 8, 2023
0
65